# Giuseppe Accogli

> Giuseppe Accogli is a venture - series unknown investor at Baxter International backing Hospital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Baxter International](https://shizune.co/investors/profile/baxter-international)
- Total investments: 1
- Last investment: Jan 2022
- Lead investor: 100%
- Last updated: Aug 2026

Giuseppe Accogli is a venture - series unknown investor at Baxter International focused on Hospital and Wellness.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Hospital | 1 | 100% |
| Wellness | 1 | 100% |
| Health Care | 1 | 100% |
| Outpatient Care | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Medically Home | Medically Home is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes. Its platform offers a virtual hospital program that connects patients with caregivers and supports the monitoring of, and communication with patients with high acuity illness that helppatients and their families to access a medical command center that provides centralized, on-demand acute medical care management from the comfort of their homes.The company was founded in 2016 and is headquartered in Boston, Massachusetts. | $110M | Venture - Series Unknown | Jan 10, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Mayo Clinic](https://shizune.co/investors/profile/mayoclinic) — VC Fund, 3 deals together
- [Cardinal Health](https://shizune.co/investors/profile/cardinal-health) — VC Fund, 2 deals together
- [Global Medical Response](https://shizune.co/investors/profile/global-medical-response) — VC Fund, 1 deal together
- [Kaiser Permanente](https://shizune.co/investors/profile/kaiser-permanente) — VC Fund, 1 deal together
- [Wormhole Capital](https://shizune.co/investors/profile/wormhole-capital) — VC Fund, 1 deal together

## About Baxter International

VC Fund · Deerfield, United States

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.The company operates through three segments: BioScience, Medication Delivery, and Renal.- The BioScience segment manufacturesrecombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines.- The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies.- The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic.Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision.The company was founded in 1931 and is headquartered in Deerfield, Illinois.

5 contacts available at Baxter International.

| Name | Title | Profile |
| --- | --- | --- |
| ​Ellen McIntosh | SVP, Associate General Counsel | https://shizune.co/investors/profile/ellen-mcintosh |
| David Ferguson | General Manager, Medication Delivery Global Business Unit | https://shizune.co/investors/profile/david-ferguson-4e16 |
| David Roman | Vice President, Strategy & FP&A | https://shizune.co/investors/profile/david-roman-3 |
| Dennis Crowley | SVP Business Development & Licensing | https://shizune.co/investors/profile/dennis-crowley-c084 |
| Giuseppe Accogli | SVP & President Global Businesses | https://shizune.co/investors/profile/giuseppe-accogli |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Giuseppe Accogli invest in?

Giuseppe Accogli invests primarily in Hospital, Wellness and Health Care startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Giuseppe Accogli last invest?

The most recent investment recorded for Giuseppe Accogli closed in Jan 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co